| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 | 5.16e-14 | 37 | 53 | 8 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 | 6.52e-14 | 38 | 53 | 8 | GO:0070001 |
| GeneOntologyMolecularFunction | CoA-transferase activity | 1.76e-07 | 5 | 53 | 3 | GO:0008410 | |
| GeneOntologyMolecularFunction | structural molecule activity | RPL23 ERVK-6 RPL27 MAP1A AHNAK ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 RIMS2 | 4.08e-07 | 891 | 53 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | peptidase activity | PRSS35 ERVK-6 DPEP3 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 NPEPL1 | 9.32e-07 | 654 | 53 | 11 | GO:0008233 |
| GeneOntologyMolecularFunction | endopeptidase activity | PRSS35 ERVK-6 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 | 1.75e-06 | 430 | 53 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 2.11e-06 | 79 | 53 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.87e-06 | 11 | 53 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | CCT6A IQCA1L ACSM3 SMC3 SLFN13 DDX54 CCT6B ACSM5 SLFN11 TOP2B | 4.16e-06 | 614 | 53 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 6.30e-06 | 14 | 53 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | succinyl-CoA:3-oxo-acid CoA-transferase activity | 6.91e-06 | 2 | 53 | 2 | GO:0008260 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 2.27e-05 | 21 | 53 | 3 | GO:0016408 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.27e-05 | 21 | 53 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 3.00e-05 | 136 | 53 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 3.00e-05 | 136 | 53 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 GALNT2 TRIM32 SLFN13 ERVK-19 KDM2A ERVK-7 SLFN11 ERVK-21 ERVK-10 ERVK-24 NPEPL1 | 5.15e-05 | 1189 | 53 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 TRIM32 SLFN13 ERVK-19 KDM2A ERVK-7 SLFN11 ERVK-21 ERVK-10 ERVK-24 | 1.01e-04 | 891 | 53 | 10 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.29e-04 | 37 | 53 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.39e-04 | 38 | 53 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.57e-04 | 441 | 53 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 1.92e-04 | 8 | 53 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.47e-04 | 46 | 53 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | nuclease activity | 3.62e-04 | 231 | 53 | 5 | GO:0004518 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 3.74e-04 | 11 | 53 | 2 | GO:0031956 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 7.10e-04 | 15 | 53 | 2 | GO:1990247 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 8.01e-04 | 417 | 53 | 6 | GO:0140098 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 1.00e-03 | 74 | 53 | 3 | GO:0016782 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.03e-03 | 18 | 53 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 1.51e-03 | 645 | 53 | 7 | GO:0140640 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA binding | 1.54e-03 | 22 | 53 | 2 | GO:0000062 | |
| GeneOntologyMolecularFunction | fatty acid derivative binding | 1.84e-03 | 24 | 53 | 2 | GO:1901567 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.84e-03 | 24 | 53 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 2.16e-03 | 26 | 53 | 2 | GO:0015645 | |
| GeneOntologyMolecularFunction | acyl-CoA binding | 2.16e-03 | 26 | 53 | 2 | GO:0120227 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 2.33e-03 | 27 | 53 | 2 | GO:0016405 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 3.06e-03 | 31 | 53 | 2 | GO:0016878 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 3.65e-03 | 238 | 53 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 4.21e-03 | 775 | 53 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 5.05e-03 | 40 | 53 | 2 | GO:0140662 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.12e-03 | 262 | 53 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 5.30e-03 | 41 | 53 | 2 | GO:0016877 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 6.45e-03 | 839 | 53 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 6.49e-03 | 840 | 53 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 6.49e-03 | 840 | 53 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 7.21e-03 | 48 | 53 | 2 | GO:0016620 | |
| GeneOntologyMolecularFunction | beta-tubulin binding | 7.51e-03 | 49 | 53 | 2 | GO:0048487 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 7.67e-03 | 152 | 53 | 3 | GO:0016779 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 8.80e-03 | 1356 | 53 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 9.71e-03 | 56 | 53 | 2 | GO:0030170 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 9.71e-03 | 56 | 53 | 2 | GO:0016903 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 1.00e-02 | 57 | 53 | 2 | GO:0070279 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.09e-02 | 1160 | 53 | 8 | GO:0030674 | |
| GeneOntologyBiologicalProcess | DNA integration | 4.50e-06 | 13 | 53 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | ketone body catabolic process | 1.94e-05 | 3 | 53 | 2 | GO:0046952 | |
| GeneOntologyBiologicalProcess | viral process | 2.25e-05 | 464 | 53 | 8 | GO:0016032 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 6.14e-05 | 83 | 53 | 4 | GO:0006278 | |
| GeneOntologyCellularComponent | chaperonin-containing T-complex | 3.29e-04 | 11 | 52 | 2 | GO:0005832 | |
| GeneOntologyCellularComponent | microbody | 7.04e-04 | 162 | 52 | 4 | GO:0042579 | |
| GeneOntologyCellularComponent | peroxisome | 7.04e-04 | 162 | 52 | 4 | GO:0005777 | |
| Domain | CoA_transf_AS | 5.42e-06 | 2 | 44 | 2 | IPR004164 | |
| Domain | CoA_trans_fam_I | 5.42e-06 | 2 | 44 | 2 | IPR004165 | |
| Domain | CoA_transf_BS | 5.42e-06 | 2 | 44 | 2 | IPR004163 | |
| Domain | CoA_trans | 5.42e-06 | 2 | 44 | 2 | PF01144 | |
| Domain | 3-oxoacid_CoA-transf_A | 5.42e-06 | 2 | 44 | 2 | IPR012792 | |
| Domain | 3-oxoacid_CoA-transf_B | 5.42e-06 | 2 | 44 | 2 | IPR012791 | |
| Domain | CoA_trans | 5.42e-06 | 2 | 44 | 2 | SM00882 | |
| Domain | 3-oxoacid_CoA-transferase | 5.42e-06 | 2 | 44 | 2 | IPR014388 | |
| Domain | Chap_CCT_zeta | 5.42e-06 | 2 | 44 | 2 | IPR012722 | |
| Domain | COA_TRANSF_2 | 5.42e-06 | 2 | 44 | 2 | PS01274 | |
| Domain | COA_TRANSF_1 | 5.42e-06 | 2 | 44 | 2 | PS01273 | |
| Domain | DUF2075 | 1.62e-05 | 3 | 44 | 2 | IPR018647 | |
| Domain | DUF2075 | 1.62e-05 | 3 | 44 | 2 | PF09848 | |
| Domain | SCP2_sterol-bd_dom | 5.40e-05 | 5 | 44 | 2 | IPR003033 | |
| Domain | YTH | 5.40e-05 | 5 | 44 | 2 | PS50882 | |
| Domain | YTH_domain | 5.40e-05 | 5 | 44 | 2 | IPR007275 | |
| Domain | - | 5.40e-05 | 5 | 44 | 2 | 3.30.1050.10 | |
| Domain | YTH | 5.40e-05 | 5 | 44 | 2 | PF04146 | |
| Domain | SCP2 | 5.40e-05 | 5 | 44 | 2 | PF02036 | |
| Domain | AlbA_2 | 1.13e-04 | 7 | 44 | 2 | PF04326 | |
| Domain | Schlafen | 1.13e-04 | 7 | 44 | 2 | IPR029684 | |
| Domain | Schlafen_AAA_dom | 1.13e-04 | 7 | 44 | 2 | IPR007421 | |
| Domain | Chaperonin_TCP-1_CS | 1.93e-04 | 9 | 44 | 2 | IPR002194 | |
| Domain | Chaprnin_Cpn60 | 1.93e-04 | 9 | 44 | 2 | IPR001844 | |
| Domain | Chaperone_TCP-1 | 2.41e-04 | 10 | 44 | 2 | IPR017998 | |
| Domain | TCP1_1 | 2.41e-04 | 10 | 44 | 2 | PS00750 | |
| Domain | TCP1_2 | 2.41e-04 | 10 | 44 | 2 | PS00751 | |
| Domain | TCP1_3 | 2.41e-04 | 10 | 44 | 2 | PS00995 | |
| Domain | - | 2.94e-04 | 11 | 44 | 2 | 3.30.260.10 | |
| Domain | TCP-1-like_intermed | 2.94e-04 | 11 | 44 | 2 | IPR027410 | |
| Domain | SDR_fam | 3.10e-04 | 56 | 44 | 3 | IPR002347 | |
| Domain | - | 4.85e-04 | 14 | 44 | 2 | 1.10.560.10 | |
| Domain | GROEL-like_equatorial | 4.85e-04 | 14 | 44 | 2 | IPR027413 | |
| Domain | Cpn60/TCP-1 | 5.59e-04 | 15 | 44 | 2 | IPR002423 | |
| Domain | Cpn60_TCP1 | 5.59e-04 | 15 | 44 | 2 | PF00118 | |
| Domain | - | 5.59e-04 | 15 | 44 | 2 | 3.50.7.10 | |
| Domain | GroEL-like_apical_dom | 5.59e-04 | 15 | 44 | 2 | IPR027409 | |
| Domain | AMP-bd_C | 7.21e-04 | 17 | 44 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 7.21e-04 | 17 | 44 | 2 | PF13193 | |
| Domain | AMP-binding_CS | 1.70e-03 | 26 | 44 | 2 | IPR020845 | |
| Domain | AMP_BINDING | 1.97e-03 | 28 | 44 | 2 | PS00455 | |
| Domain | AMP-binding | 2.26e-03 | 30 | 44 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 2.26e-03 | 30 | 44 | 2 | IPR000873 | |
| Domain | Sc_DH/Rdtase_CS | 3.07e-03 | 35 | 44 | 2 | IPR020904 | |
| Domain | - | 3.80e-03 | 39 | 44 | 2 | 3.40.640.10 | |
| Domain | PyrdxlP-dep_Trfase | 4.20e-03 | 41 | 44 | 2 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 4.20e-03 | 41 | 44 | 2 | IPR015421 | |
| Pathway | KEGG_BUTANOATE_METABOLISM | 1.31e-10 | 34 | 33 | 6 | M3397 | |
| Pathway | KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION | 3.16e-06 | 44 | 33 | 4 | M11835 | |
| Pathway | REACTOME_UTILIZATION_OF_KETONE_BODIES | 3.18e-05 | 4 | 33 | 2 | MM15459 | |
| Pathway | REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA | 5.29e-05 | 5 | 33 | 2 | M27725 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | 8.01e-05 | 99 | 33 | 4 | M46448 | |
| Pathway | REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC | 2.36e-04 | 10 | 33 | 2 | M27299 | |
| Pathway | REACTOME_KETONE_BODY_METABOLISM | 2.36e-04 | 10 | 33 | 2 | MM15437 | |
| Pathway | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | 2.36e-04 | 10 | 33 | 2 | MM15004 | |
| Pathway | REACTOME_KETONE_BODY_METABOLISM | 2.36e-04 | 10 | 33 | 2 | M27706 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 2.79e-04 | 757 | 33 | 8 | M27451 | |
| Pathway | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS | 2.88e-04 | 11 | 33 | 2 | M27719 | |
| Pathway | WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION | 6.25e-04 | 16 | 33 | 2 | MM15841 | |
| Pathway | WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION | 7.07e-04 | 17 | 33 | 2 | M39365 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 7.24e-04 | 176 | 33 | 4 | M27854 | |
| Pathway | WP_16P112_PROXIMAL_DELETION_SYNDROME | 7.31e-04 | 76 | 33 | 3 | M40057 | |
| Pathway | WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS | 8.86e-04 | 19 | 33 | 2 | M48049 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ASSEMBLY_AND_TRAFFICKING_OF_TELOMERASE | 8.86e-04 | 19 | 33 | 2 | M47863 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.67e-03 | 26 | 33 | 2 | M9648 | |
| Pathway | REACTOME_PROTEIN_LOCALIZATION | 1.76e-03 | 103 | 33 | 3 | MM15653 | |
| Pathway | REACTOME_NONSENSE_MEDIATED_DECAY_NMD | 2.41e-03 | 115 | 33 | 3 | MM15640 | |
| Pathway | REACTOME_NONSENSE_MEDIATED_DECAY_NMD | 2.47e-03 | 116 | 33 | 3 | M27921 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.68e-03 | 33 | 33 | 2 | M27297 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 2.83e-03 | 620 | 33 | 6 | MM15193 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 6.77e-15 | 5 | 53 | 5 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 | 1.68e-12 | 94 | 53 | 8 | 21542922 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.80e-12 | 4 | 53 | 4 | 10469592 | |
| Pubmed | 5.71e-11 | 18 | 53 | 5 | 18664271 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 10516026 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL23 RPL27 CCT6A SMG8 OXCT1 SMC3 TRIM32 SGPL1 AHNAK DDX54 CCT6B KDM2A ALDH9A1 TOP2B | 9.87e-09 | 1353 | 53 | 14 | 29467282 |
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 7983737 | ||
| Pubmed | 1.22e-07 | 542 | 53 | 9 | 14651853 | ||
| Pubmed | 3.98e-07 | 10 | 53 | 3 | 12970426 | ||
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | PRSS35 ACSM3 OXCT1 ACADS HSDL2 DHRS4L1 OXCT2 SCP2 FIS1 ALAS1 ALDH9A1 | 4.18e-07 | 1047 | 53 | 11 | 18614015 |
| Pubmed | 7.28e-07 | 12 | 53 | 3 | 14557543 | ||
| Pubmed | Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry. | 8.91e-07 | 343 | 53 | 7 | 28130547 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | PRSS35 ACSM3 OXCT1 ACADS HSDL2 SCP2 ACSM5 FIS1 ALAS1 ALDH9A1 | 1.18e-06 | 926 | 53 | 10 | 20877624 |
| Pubmed | 1.62e-06 | 129 | 53 | 5 | 23022380 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 12534938 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 37833372 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 2.28e-06 | 2 | 53 | 2 | 9460924 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.28e-06 | 2 | 53 | 2 | 11672541 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29563550 | ||
| Pubmed | RPL23 RPL27 CCT6A GALNT2 SMC3 TRIM32 AHNAK KDM2A ALDH9A1 NPEPL1 GNS | 3.36e-06 | 1297 | 53 | 11 | 33545068 | |
| Pubmed | 4.90e-06 | 847 | 53 | 9 | 35850772 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 11756565 | ||
| Pubmed | Tissue-specific subunit of the mouse cytosolic chaperonin-containing TCP-1. | 6.83e-06 | 3 | 53 | 2 | 9013858 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 38875319 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 26318451 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.69e-05 | 989 | 53 | 9 | 36424410 | |
| Pubmed | 1.83e-05 | 102 | 53 | 4 | 26584622 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 2.14e-05 | 558 | 53 | 7 | 35063084 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 29528433 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 18355440 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 2.27e-05 | 5 | 53 | 2 | 11401426 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 24089532 | ||
| Pubmed | The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. | 2.46e-05 | 110 | 53 | 4 | 18307411 | |
| Pubmed | 2.51e-05 | 382 | 53 | 6 | 29222160 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 31202577 | ||
| Pubmed | Schlafen, a new family of growth regulatory genes that affect thymocyte development. | 3.40e-05 | 6 | 53 | 2 | 9846487 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 15063128 | ||
| Pubmed | TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease. | 4.76e-05 | 7 | 53 | 2 | 21699783 | |
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 15351786 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 4.85e-05 | 430 | 53 | 6 | 38172120 | |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | 4.99e-05 | 1136 | 53 | 9 | 34800366 | |
| Pubmed | 5.09e-05 | 1139 | 53 | 9 | 36417873 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 5.55e-05 | 268 | 53 | 5 | 33024031 | |
| Pubmed | 6.17e-05 | 1168 | 53 | 9 | 19946888 | ||
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 19619625 | ||
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 7828721 | ||
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 10336634 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 9.04e-05 | 701 | 53 | 7 | 30196744 | |
| Pubmed | 9.11e-05 | 952 | 53 | 8 | 38569033 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 9.28e-05 | 704 | 53 | 7 | 29955894 | |
| Pubmed | 1.00e-04 | 713 | 53 | 7 | 29802200 | ||
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 7953530 | ||
| Pubmed | 1.41e-04 | 327 | 53 | 5 | 31409639 | ||
| Pubmed | 1.47e-04 | 330 | 53 | 5 | 32529326 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.55e-04 | 1318 | 53 | 9 | 30463901 | |
| Pubmed | 1.69e-04 | 340 | 53 | 5 | 24332808 | ||
| Pubmed | 1.81e-04 | 547 | 53 | 6 | 37267103 | ||
| Pubmed | 1.83e-04 | 786 | 53 | 7 | 29128334 | ||
| Pubmed | The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors. | 1.94e-04 | 350 | 53 | 5 | 26549023 | |
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 23620142 | ||
| Pubmed | 2.09e-04 | 803 | 53 | 7 | 36517590 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.19e-04 | 1082 | 53 | 8 | 38697112 | |
| Pubmed | 2.35e-04 | 197 | 53 | 4 | 23686814 | ||
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 17925232 | ||
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 30955883 | ||
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 2.43e-04 | 79 | 53 | 3 | 26446488 | |
| Pubmed | 2.79e-04 | 206 | 53 | 4 | 34185411 | ||
| Pubmed | 2.82e-04 | 844 | 53 | 7 | 25963833 | ||
| Pubmed | 3.05e-04 | 17 | 53 | 2 | 21572988 | ||
| Pubmed | 3.14e-04 | 859 | 53 | 7 | 31536960 | ||
| Pubmed | 3.46e-04 | 397 | 53 | 5 | 21319273 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.50e-04 | 398 | 53 | 5 | 35016035 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 3.94e-04 | 1496 | 53 | 9 | 32877691 | |
| Pubmed | 4.11e-04 | 638 | 53 | 6 | 33239621 | ||
| Pubmed | Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function. | 4.14e-04 | 413 | 53 | 5 | 27499296 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 4.14e-04 | 639 | 53 | 6 | 23443559 | |
| Pubmed | 4.21e-04 | 641 | 53 | 6 | 36057605 | ||
| Pubmed | PSMD9 ribosomal protein network maintains nucleolar architecture and WT p53 levels. | 4.25e-04 | 20 | 53 | 2 | 34077860 | |
| Pubmed | 4.42e-04 | 419 | 53 | 5 | 15635413 | ||
| Pubmed | 4.52e-04 | 234 | 53 | 4 | 36243803 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 4.70e-04 | 21 | 53 | 2 | 27626377 | |
| Pubmed | 5.41e-04 | 438 | 53 | 5 | 32628020 | ||
| Pubmed | 5.57e-04 | 441 | 53 | 5 | 12853948 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 5.66e-04 | 678 | 53 | 6 | 30209976 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 5.69e-04 | 949 | 53 | 7 | 36574265 | |
| Pubmed | 5.79e-04 | 250 | 53 | 4 | 33536335 | ||
| Pubmed | 5.88e-04 | 251 | 53 | 4 | 31076518 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 5.95e-04 | 1257 | 53 | 8 | 36526897 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 6.33e-04 | 256 | 53 | 4 | 35777956 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 6.33e-04 | 256 | 53 | 4 | 24189400 | |
| Pubmed | The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine. | 6.68e-04 | 25 | 53 | 2 | 35874829 | |
| Pubmed | 6.68e-04 | 25 | 53 | 2 | 20301702 | ||
| Pubmed | 6.68e-04 | 25 | 53 | 2 | 19372376 | ||
| Pubmed | 6.70e-04 | 260 | 53 | 4 | 36199071 | ||
| Pubmed | 6.94e-04 | 463 | 53 | 5 | 34901782 | ||
| Pubmed | 7.09e-04 | 708 | 53 | 6 | 39231216 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 7.10e-04 | 264 | 53 | 4 | 32814769 | |
| Pubmed | 7.15e-04 | 1293 | 53 | 8 | 15342556 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 7.19e-04 | 1294 | 53 | 8 | 30804502 | |
| Interaction | ELF5 interactions | 2.84e-05 | 147 | 49 | 5 | int:ELF5 | |
| Interaction | ERVK-6 interactions | 3.46e-05 | 4 | 49 | 2 | int:ERVK-6 | |
| Interaction | OXCT2 interactions | 5.24e-05 | 30 | 49 | 3 | int:OXCT2 | |
| Interaction | MAPT interactions | YTHDF1 RPL23 RPL27 OXCT1 MAP1A SMC3 AHNAK ARL6IP5 CCT6B ALDH9A1 NPEPL1 | 6.10e-05 | 1119 | 49 | 11 | int:MAPT |
| Interaction | MIPEP interactions | 6.19e-05 | 88 | 49 | 4 | int:MIPEP | |
| Interaction | CAPN10 interactions | 6.38e-05 | 32 | 49 | 3 | int:CAPN10 | |
| Interaction | PLA2G15 interactions | 8.37e-05 | 35 | 49 | 3 | int:PLA2G15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 2.56e-05 | 149 | 52 | 4 | chr17q12 | |
| Cytoband | 17q12 | 1.99e-04 | 99 | 52 | 3 | 17q12 | |
| GeneFamily | Schlafen family | 4.83e-05 | 7 | 28 | 2 | 1110 | |
| GeneFamily | Chaperonins | 2.40e-04 | 15 | 28 | 2 | 587 | |
| GeneFamily | Acyl-CoA synthetase family | 7.35e-04 | 26 | 28 | 2 | 40 | |
| GeneFamily | L ribosomal proteins | 2.81e-03 | 51 | 28 | 2 | 729 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 6.14e-03 | 76 | 28 | 2 | 743 | |
| GeneFamily | PHD finger proteins | 8.52e-03 | 90 | 28 | 2 | 88 | |
| GeneFamily | PDZ domain containing | 2.30e-02 | 152 | 28 | 2 | 1220 | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.61e-08 | 189 | 45 | 6 | 7f78b5bb8195f99b18082cbb612e9199b7a1538c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.62e-06 | 197 | 45 | 5 | ad6f047d003c08413264f39a30ba0f7639a257cd | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 169 | 45 | 4 | 922086f218135b734b7d370b871923e50141edce | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 169 | 45 | 4 | ee27bcfe3f9a295ec5fb0a375d77d1050e5cbaad | |
| ToppCell | mild_COVID-19_(asymptomatic)-Neutrophil|World / disease group, cell group and cell class (v2) | 4.09e-05 | 66 | 45 | 3 | e71738a3a84be93053d1ed20d030e4c606f8f402 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.18e-05 | 192 | 45 | 4 | 38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 4.44e-05 | 195 | 45 | 4 | c3280bb6219e2eff5e24ef45aa2d76479a562122 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.62e-05 | 197 | 45 | 4 | 1638959d7aecb9fc5285eb7e4a3103ca437989e2 | |
| ToppCell | distal-Hematologic-Platelet/Megakaryocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.62e-05 | 197 | 45 | 4 | e28b1b154d9588dce07c123b36f7f01fa90a5fc1 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.71e-05 | 198 | 45 | 4 | d12f37527399038a8f030b45b176bda5c7c8a7ad | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.71e-05 | 198 | 45 | 4 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | 18-Distal|18 / Age, Tissue, Lineage and Cell class | 4.71e-05 | 198 | 45 | 4 | d635398c6529c514e77c0dc9299e9cf00330c9e7 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.71e-05 | 198 | 45 | 4 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | mild-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.71e-05 | 198 | 45 | 4 | ba97ff6e9d400b53ad013dce54afd7154a0f4fc9 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-05 | 199 | 45 | 4 | 83383d9ae4f501754fd3da0215ce6f0e3c70562c | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.80e-05 | 199 | 45 | 4 | 5b140ac88ebc25ce397ae577e48f3e271faf46e7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.80e-05 | 199 | 45 | 4 | d946db0e8cc3fbed2d0eb9b4346400138d43219f | |
| ToppCell | severe-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.89e-05 | 200 | 45 | 4 | 2f1218c9884fabae952cdbff25b6baa7bae9e732 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Htra1)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.03e-05 | 86 | 45 | 3 | c1181a7e9f4cbde5a3bee7b54d6448dfce58b238 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Htra1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.03e-05 | 86 | 45 | 3 | 4263673abf183f2e04f1a2bf37e365a25b8cb0b4 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Htra1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.03e-05 | 86 | 45 | 3 | c6c0e8e562ffc705e0cd3f503a9e43ca2669e9b0 | |
| Computational | Genes in the cancer module 184. | 6.15e-05 | 29 | 29 | 3 | MODULE_184 | |
| Drug | butyraldehyde | 2.66e-06 | 48 | 46 | 4 | CID000000261 | |
| Drug | AC1L3UHX | 3.99e-06 | 2 | 46 | 2 | CID000095516 | |
| Drug | AC1NQZW7 | 3.99e-06 | 2 | 46 | 2 | CID005282334 | |
| Drug | CPD-627 | 3.99e-06 | 2 | 46 | 2 | CID000439367 | |
| Drug | AC1LCVNZ | 3.99e-06 | 2 | 46 | 2 | CID000656887 | |
| Drug | naphthyl-2-methyl-succinate | 3.99e-06 | 2 | 46 | 2 | CID000656886 | |
| Drug | AC1L9DYZ | 4.24e-06 | 16 | 46 | 3 | CID000443062 | |
| Drug | coproporphyrinogen I | 6.17e-06 | 18 | 46 | 3 | CID000440776 | |
| Drug | aminocarnitine | 8.59e-06 | 20 | 46 | 3 | CID000121830 | |
| Drug | N-acetylcysteamine | 1.00e-05 | 21 | 46 | 3 | CID000014484 | |
| Drug | 4-PA | 1.16e-05 | 22 | 46 | 3 | CID000061138 | |
| Drug | AC1L19X5 | 1.16e-05 | 22 | 46 | 3 | CID000000741 | |
| Drug | p-azidobenzoyl-CoA | 1.20e-05 | 3 | 46 | 2 | CID000194163 | |
| Drug | oxfenicine | 1.33e-05 | 23 | 46 | 3 | CID000036143 | |
| Drug | AC1L975Q | 1.52e-05 | 24 | 46 | 3 | CID000439337 | |
| Drug | AC1L2LUF | 2.39e-05 | 4 | 46 | 2 | CID000074406 | |
| Drug | C4:1n-2 | 2.44e-05 | 28 | 46 | 3 | CID000019499 | |
| Drug | 3HB-4HB | 3.98e-05 | 5 | 46 | 2 | CID003081116 | |
| Drug | AC1NS1NJ | 3.98e-05 | 5 | 46 | 2 | CID005327101 | |
| Drug | monoacetoacetin | 3.98e-05 | 5 | 46 | 2 | CID000125624 | |
| Drug | acrylyl-coenzyme A | 5.71e-05 | 37 | 46 | 3 | CID000439340 | |
| Drug | AC1NQZWS | 5.96e-05 | 6 | 46 | 2 | CID005282341 | |
| Drug | 2-bromobutyrate | 5.96e-05 | 6 | 46 | 2 | CID000006655 | |
| Drug | AC1MRLG6 | 5.96e-05 | 6 | 46 | 2 | CID003519889 | |
| Drug | AND-CoA | 6.46e-05 | 107 | 46 | 4 | CID003083159 | |
| Drug | methyl 3-mercaptopropionate | 8.33e-05 | 7 | 46 | 2 | CID000018050 | |
| Drug | crotonobetainyl-CoA | 8.33e-05 | 7 | 46 | 2 | CID000000591 | |
| Drug | carboxymuconolactone | 8.33e-05 | 7 | 46 | 2 | CID000000543 | |
| Drug | AC1L19VW | 8.33e-05 | 7 | 46 | 2 | CID000000726 | |
| Drug | AC1L1BTU | 8.33e-05 | 7 | 46 | 2 | CID000001603 | |
| Drug | gamma-butyrobetaine | 8.38e-05 | 42 | 46 | 3 | CID000000134 | |
| Drug | AC1L1GAZ | 9.00e-05 | 43 | 46 | 3 | CID000003605 | |
| Drug | AC1N3SS3 | 1.03e-04 | 45 | 46 | 3 | CID000000592 | |
| Drug | 2-naphthoic acid | 1.11e-04 | 8 | 46 | 2 | CID000007123 | |
| Drug | glutaconyl-CoA | 1.11e-04 | 8 | 46 | 2 | CID009543049 | |
| Drug | l-carnityl CoA | 1.11e-04 | 8 | 46 | 2 | CID000000605 | |
| Drug | AC1L9K5A | 1.11e-04 | 8 | 46 | 2 | CID000446832 | |
| Drug | chloranilic acid | 1.11e-04 | 8 | 46 | 2 | CID000066604 | |
| Drug | AC1Q68Z5 | 1.21e-04 | 386 | 46 | 6 | CID000000181 | |
| Drug | CPD-226 | 1.42e-04 | 9 | 46 | 2 | CID000439705 | |
| Drug | U nu | 1.50e-04 | 51 | 46 | 3 | CID000023943 | |
| Drug | AC1L195D | 1.78e-04 | 10 | 46 | 2 | CID000000399 | |
| Drug | AC1L99L3 | 1.78e-04 | 10 | 46 | 2 | CID000440590 | |
| Drug | rhodoquinone | 1.78e-04 | 10 | 46 | 2 | CID006441300 | |
| Drug | carnitine | 1.91e-04 | 265 | 46 | 5 | CID000000085 | |
| Drug | 3-Hydroxybutanoyl-Coenzyme A | 2.09e-04 | 57 | 46 | 3 | CID000000521 | |
| Drug | pantetheine | 2.09e-04 | 57 | 46 | 3 | CID000000479 | |
| Drug | citramalate | 2.17e-04 | 11 | 46 | 2 | CID000001081 | |
| Drug | AC1L974K | 2.17e-04 | 11 | 46 | 2 | CID000439320 | |
| Drug | AC1L9896 | 2.17e-04 | 11 | 46 | 2 | CID000439892 | |
| Drug | benzoyl-S-CoA | 2.20e-04 | 58 | 46 | 3 | CID000122174 | |
| Drug | enol-lactone | 2.60e-04 | 12 | 46 | 2 | CID000000104 | |
| Drug | AC1L19KJ | 2.60e-04 | 12 | 46 | 2 | CID000000589 | |
| Drug | AC1L99WA | 2.60e-04 | 12 | 46 | 2 | CID000440753 | |
| Drug | 3-hydroxy-3-methylglutaric acid | 2.82e-04 | 63 | 46 | 3 | CID000001662 | |
| Drug | 5-hydroxyvalerate | 3.07e-04 | 13 | 46 | 2 | CID000025945 | |
| Disease | acetoacetate measurement | 5.78e-05 | 8 | 43 | 2 | EFO_0010111 | |
| Disease | X-17676 measurement | 5.78e-05 | 8 | 43 | 2 | EFO_0800785 | |
| Disease | Myeloid Leukemia | 3.13e-04 | 18 | 43 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.13e-04 | 18 | 43 | 2 | C0023466 | |
| Disease | intrinsic cardiomyopathy (implicated_via_orthology) | 4.28e-04 | 21 | 43 | 2 | DOID:0060036 (implicated_via_orthology) | |
| Disease | 3-hydroxybutyrate measurement | 6.09e-04 | 25 | 43 | 2 | EFO_0010982 | |
| Disease | myeloperoxidase measurement | 6.59e-04 | 26 | 43 | 2 | EFO_0005243 | |
| Disease | Anemia, Diamond-Blackfan | 8.79e-04 | 30 | 43 | 2 | C1260899 | |
| Disease | clopidogrel metabolite measurement | 1.06e-03 | 33 | 43 | 2 | EFO_0007966 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TNLGPKGTMKMLVSG | 36 | P40227 | |
| KGTMKMLVSGAGDIK | 41 | P40227 | |
| TGMKIMEMSAKGIKP | 236 | P49189 | |
| VKKMGGLGLLAMDVP | 71 | P16219 | |
| GKMKGTKVKTPEMII | 481 | Q09666 | |
| NPKGMKIKSGSMGKA | 381 | Q6NUN0 | |
| GPLGVKLMSVESKKM | 366 | Q8IWF9 | |
| GGMRPGKKVLVMGIV | 46 | Q3ZCW2 | |
| MSKGLVNGLKAGPMA | 2666 | P78559 | |
| GVMPKMDIISGTLGK | 431 | P13196 | |
| MIKAVVPEMEKRGGG | 151 | P0CG22 | |
| IKTPMIAGGLFVMDK | 301 | Q10471 | |
| MGLSYPVFKGIMKKG | 101 | Q8TDD1 | |
| RGEKMKGKMVSQVPS | 886 | Q5VYM1 | |
| KAMKKDGLVGMAIVG | 116 | Q9Y3D6 | |
| IKGKTTMPGMKRDCG | 271 | Q8NDH3 | |
| SGKLKPTMAFMSGKL | 381 | Q6YN16 | |
| PTMAFMSGKLKIKGN | 386 | Q6YN16 | |
| GAMLGLKVVGGKMTE | 676 | Q9UQ26 | |
| GVGDMVMATVKKGKP | 56 | P62829 | |
| MKKFGGPGRMKQSCV | 591 | Q9Y2K7 | |
| PLKKTKALIGEMGMT | 66 | P15586 | |
| LKKNGGIVMVTLSMG | 311 | Q9H4B8 | |
| MGKFMKPGKVVLVLA | 1 | P61353 | |
| PGSGKTIMAMKIMEK | 601 | Q68D06 | |
| KVMKVMGSGPKESAL | 866 | Q8ND04 | |
| LFLKKMGAKGSTPGM | 356 | Q13049 | |
| TNLGPKGTMKMLVSG | 36 | Q92526 | |
| KGTMKMLVSGAGDIK | 41 | Q92526 | |
| KLVPGGKATLVMKKG | 1046 | Q9UQE7 | |
| MSGKAIKGKVGKPKV | 1211 | Q02880 | |
| GNFLPKTKMAKMIGE | 256 | Q9NYW6 | |
| PMSKGMKAGKPVVAA | 1161 | Q7Z7B0 | |
| RSILLVGPSGMGKKM | 561 | A6NCM1 | |
| VGPSGMGKKMLVKAV | 566 | A6NCM1 | |
| KMEGIGLKRTPMGIV | 151 | O75915 | |
| PGSGKTIMAMKIMEK | 601 | Q7Z7L1 | |
| PGKMVKGMGGAMDLV | 416 | P55809 | |
| GKLKITGNMGLAMKL | 521 | P22307 | |
| MIPGKKVKGMGGAMD | 411 | Q9BYC2 | |
| IMKNPKAKTTGMGAI | 511 | O95470 | |
| MGKLPGTRMAALKAK | 56 | Q8IYE0 | |
| GNFKGMKIKPGSMGK | 386 | Q53FZ2 | |
| QKIMTKMGYIPGKGL | 116 | P63129 | |
| QKIMTKMGYIPGKGL | 116 | P63121 | |
| MELGISPTIKKMPGG | 291 | Q8N3Z0 | |
| QKIMTKMGYIPGKGL | 116 | P63131 | |
| KKKVVKYGMGGMIIV | 2396 | Q9H5I5 | |
| QKIMTKMGYIPGKGL | 116 | Q9Y6I0 | |
| QKIMTKMGYIPGKGL | 116 | P63125 | |
| MVPGGTMKSLKKDSR | 1 | Q8TBZ2 | |
| QKIMTKMGYIPGKGL | 116 | P10265 | |
| PAGMSAKMLGGVFKI | 431 | Q96MU7 | |
| QKIMTKMGYIPGKGL | 116 | P63123 | |
| LSPLMMAAKTGKIGI | 371 | Q9HBA0 | |
| QKIMTKMGYIPGKGL | 116 | P63119 | |
| PKMKTKSGPVMGGGL | 246 | Q9BYJ9 | |
| QKIMTKMGYIPGKGL | 116 | P63124 | |
| QKIMTKMGYILGKGL | 116 | P63120 | |
| KKVMAQGSIGVAPGM | 3436 | O14686 |